Pharmavoice Podcasts

China: An Emerging Market for Cancer Therapeutics

Informações:

Sinopsis

Date Posted: 12/30/2010Size: 6.12MBLength: 00:13:48Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar HealthIn this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.Play PodcastDownload transcript and white paperFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.